Abbott Laboratories To Voluntarily Delist From NYSE Arca; Company Retains New York Stock Exchange Listing

ABBOTT PARK, Ill., Dec. 20 /PRNewswire-FirstCall/ -- Abbott today announced that it plans to voluntarily delist its common stock from NYSE Arca, Inc., formerly known as the Pacific Exchange. Abbott will maintain its current listing - under ticker symbol "ABT" - on the New York Stock Exchange.

Abbott's decision follows the recent merger of NYSE Group with Archipelago Holdings, the parent company of NYSE Arca, and will eliminate duplicative administrative requirements associated with a listing on both exchanges. Trading of Abbott shares on the facilities of NYSE Arca will still be available on an unlisted basis.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com .

Abbott

CONTACT: Media, Scott Stoffel, +1-847-936-9502, or Financial Community,Larry Peepo, +1-847-935-6722, both of Abbott

MORE ON THIS TOPIC